World's Best Scientists 2026 revealed!
Dafna D. Gladman

Dafna D. Gladman

Award Badge
Best Scientists
2025
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
167
Citations
127236
World Ranking
73
National Ranking
2

Best Scientists

D-Index
167
Citations
127236
World Ranking
964
National Ranking
20

Medicine

D-Index
167
Citations
134573
World Ranking
580
National Ranking
16

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award
  • 2025 - Research.com Best Scientists Award
  • 2023 - Research.com Medicine in Canada Leader Award

Overview

Dafna D. Gladman is affiliated with Toronto Western Hospital in Canada and has an extensive research background in medicine, particularly focusing on rheumatology and immunology. Their scholarly contributions primarily involve studies on autoimmune and inflammatory disorders, with significant work related to systemic lupus erythematosus, psoriatic arthritis, and rheumatoid arthritis.

The scientist has published over 700 works, with the main fields of study identified as Medicine and Immunology and Microbiology. Their subfields emphasize Rheumatology, Immunology, Hematology, Pathology and Forensic Medicine, and Radiology, Nuclear Medicine and Imaging.

Their research topics cover a broad spectrum, including:

  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Atherosclerosis and Cardiovascular Diseases
  • Monoclonal and Polyclonal Antibodies Research

Some notable recent papers authored by or associated with Dafna D. Gladman include:

  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update (2023), published in Annals of the Rheumatic Diseases
  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 (2022), published in Nature Reviews Rheumatology
  • Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE) (2022), published in The Lancet
  • Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort (2021), published in Lara D. Veeken
  • National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments (2021), published in Journal of the American Academy of Dermatology

Dafna D. Gladman frequently collaborates with other researchers, with the most frequent co-authors being:

  • Philip J. Mease
  • Murray B. Urowitz
  • Laura C. Coates
  • Vinod Chandran
  • Zahi Touma

Their work is commonly published in venues such as:

  • Annals of the Rheumatic Diseases
  • The Journal of Rheumatology
  • Lara D. Veeken
  • Seminars in Arthritis and Rheumatism
  • Arthritis Care & Research

Best Publications

  • Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

    C. Bombardier;D. D. Gladman;M. B. Urowitz;D. Caron

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

    Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

    William Taylor;Dafna Gladman;Philip Helliwell;Antonio Marchesoni

  • Systemic lupus erythematosus disease activity index 2000.

    Dafna D Gladman;Dominique Ibañez;Murray B Urowitz

  • The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

    Dafna Gladman;Ellen Ginzler;Charles Goldsmith;Paul Fortin

  • Psoriatic arthritis: epidemiology, clinical features, course, and outcome

    D D Gladman;C Antoni;P Mease;D O Clegg

  • Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways

    Rajan P. Nair;Kristina Callis Duffin;Cynthia Helms;Jun Ding

  • Methods for assessing responsiveness: a critical review and recommendations

    Janice A. Husted;Richard J. Cook;Vern T. Farewell;Dafna D. Gladman

  • Mortality in systemic lupus erythematosus.

    S. Bernatsky;J. F. Boivin;L. Joseph;S. Manzi

  • Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

    Philip P.J. Mease;Dafna D.D. Gladman;Christopher C.T. Ritchlin;Eric E.M. Ruderman

  • Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

    Lam C. Tsoi;Sarah L. Spain;Sarah L. Spain;Jo Knight;Eva Ellinghaus;Eva Ellinghaus

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D M Evans;Spencer Cca.;J J Pointon;Z Su

  • Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

    Christian E. Antoni;Arthur Kavanaugh;Bruce Kirkham;Zuhre Tutuncu

  • Psoriatic Arthritis (PSA) - An Analysis of 220 Patients

    D D Gladman;R Shuckett;M L Russell;J C Thorne

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

    A Cortes;J Hadler;J P Pointon

  • Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

    Arthur Kavanaugh;Iain McInnes;Philip Mease;Gerald G. Krueger

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D.M. Evans;C.C.A. Spencer;J.J. Pointon;Z. Su

Frequent Co-Authors

Murray B. Urowitz
Murray B. Urowitz University of Toronto
Philip J. Mease
Philip J. Mease University of Washington
Paul R. Fortin
Paul R. Fortin Université Laval
Ian N. Bruce
Ian N. Bruce University of Manchester
Caroline Gordon
Caroline Gordon University of Birmingham
Rosalind Ramsey-Goldman
Rosalind Ramsey-Goldman Northwestern University
Susan Manzi
Susan Manzi Allegheny Health Network
Vernon T. Farewell
Vernon T. Farewell University of Cambridge
Graciela S. Alarcón
Graciela S. Alarcón University of Alabama at Birmingham
Michelle Petri
Michelle Petri Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medical studies but looking for flexible or alternative paths, there are several online degrees and career options worth exploring. For those who want to delve into pharmaceutical sciences, enrolling in the best online pharmacy school programs can open doors to clinical or research roles in pharmacy. These online doctorate options combine affordable tuition with reputable coursework.

Health Information Management (HIM) is another in-demand field in healthcare. Accredited him programs focus on digital health records and information governance, preparing graduates for roles that bridge technology and patient care.

For those seeking a quicker entry point into healthcare administration, the cheapest medical billing and coding online courses provide vital training in managing healthcare reimbursements and records – often in less time and with lower costs.

Aspiring advanced practice nurses can consider the cheapest online nurse practitioner programs to qualify for high-level clinical roles. These flexible programs offer a fast-track to becoming a licensed nurse practitioner while balancing study and work.

Best Scientists Citing Dafna D. Gladman

Trending Scientists